Henry Schein Inc. (NASDAQ:HSIC) has received an average recommendation of “Hold” from the twelve analysts that are covering the stock. Seven investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $151.78.
HSIC has been the subject of several research reports. Bank of America Corp. initiated coverage on Henry Schein in a research note on Monday, September 12th. They set a “buy” rating and a $185.00 price objective for the company. Zacks Investment Research upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Monday, September 12th. Finally, Robert W. Baird reiterated an “outperform” rating and set a $176.00 price objective (up from $175.00) on shares of Henry Schein in a research note on Tuesday.
In related news, Director Paul Brons sold 3,381 shares of the company’s stock in a transaction that occurred on Monday, August 29th. The stock was sold at an average price of $164.03, for a total value of $554,585.43. Following the transaction, the director now directly owns 13,715 shares in the company, valued at $2,249,671.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.27% of the stock is owned by corporate insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Advisor Group Inc. purchased a new position in Henry Schein during the second quarter worth approximately $106,000. Global X Management Co. LLC boosted its position in Henry Schein by 18.7% in the second quarter. Global X Management Co. LLC now owns 661 shares of the company’s stock worth $117,000 after buying an additional 104 shares during the period. Quadrant Capital Group LLC boosted its position in Henry Schein by 0.4% in the second quarter. Quadrant Capital Group LLC now owns 742 shares of the company’s stock worth $128,000 after buying an additional 3 shares during the period. Van ECK Associates Corp boosted its position in Henry Schein by 29.1% in the second quarter. Van ECK Associates Corp now owns 727 shares of the company’s stock worth $129,000 after buying an additional 164 shares during the period. Finally, Mizuho Asset Management Co. Ltd. boosted its position in Henry Schein by 108.6% in the second quarter. Mizuho Asset Management Co. Ltd. now owns 1,018 shares of the company’s stock worth $180,000 after buying an additional 530 shares during the period. Institutional investors own 91.98% of the company’s stock.
Shares of Henry Schein (NASDAQ:HSIC) traded up 0.66% during midday trading on Thursday, hitting $162.40. The stock had a trading volume of 174,973 shares. Henry Schein has a 52-week low of $137.70 and a 52-week high of $183.00. The firm’s 50 day moving average price is $162.55 and its 200 day moving average price is $170.55. The firm has a market cap of $13.28 billion, a price-to-earnings ratio of 27.51 and a beta of 1.05.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Thursday, August 4th. The company reported $1.64 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.63 by $0.01. Henry Schein had a return on equity of 17.84% and a net margin of 4.42%. The company earned $2.87 billion during the quarter, compared to analyst estimates of $2.85 billion. During the same period in the previous year, the business earned $1.46 EPS. Henry Schein’s quarterly revenue was up 9.3% on a year-over-year basis. On average, equities research analysts expect that Henry Schein will post $6.57 earnings per share for the current year.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.